Filed: 11/13/2024ACC: 0001104659-24-117589
📋 What this filing means
SOFINNOVA INVESTMENTS, INC. filed this quarterly 13F‑HR report disclosing 58 equity positions with a total reported market value of $1.26B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
58
Positions
$1.26B
Total AUM (reported)
60.92M
Total Shares
Allocation by class
COM$909.71M72.2%
CL A$123.49M9.8%
ADR$86.48M6.9%
SPONSORED ADR$86.06M6.8%
SHS USD$21.01M1.7%
COM PAR $.01$20.90M1.7%
CL A COM$5.36M0.4%
Portfolio Concentration
Top 3$406.79M32.3%
4–10$357.66M28.4%
11–25$338.64M26.9%
Rest$156.90M12.5%
Top 3 weight
32.3%
Top 10 weight
60.7%
Voting Authority Distribution
Total shares with voting rights: 60.92M
Sole
Full voting authority
60.92M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole58
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings58
Rows:
Natera Inc
SOLEShares1.55M
TypeSH
Market value$196.81M
15.62%
Sole
1.55M
Shared
0.00
None
0.00
Vera Therapeutics Inc
SOLEShares2.79M
TypeSH
Market value$123.49M
9.80%
Sole
2.79M
Shared
0.00
None
0.00
Novo-Nordisk A S
SOLEShares726.33K
TypeSH
Market value$86.48M
6.86%
Sole
726.33K
Shared
0.00
None
0.00
AstraZeneca PLC
SOLEShares809.41K
TypeSH
Market value$63.06M
5.00%
Sole
809.41K
Shared
0.00
None
0.00
IDEAYA Biosciences Inc
SOLEShares1.75M
TypeSH
Market value$55.42M
4.40%
Sole
1.75M
Shared
0.00
None
0.00
Elanco Animal Health Inc
SOLEShares3.52M
TypeSH
Market value$51.69M
4.10%
Sole
3.52M
Shared
0.00
None
0.00
BioAge Labs Inc
SOLEShares2.30M
TypeSH
Market value$47.94M
3.80%
Sole
2.30M
Shared
0.00
None
0.00
Axsome Therapeutics Inc
SOLEShares529.53K
TypeSH
Market value$47.59M
3.78%
Sole
529.53K
Shared
0.00
None
0.00
Incyte Corp
SOLEShares714.18K
TypeSH
Market value$47.21M
3.75%
Sole
714.18K
Shared
0.00
None
0.00
Soleno Therapeutics Inc
SOLEShares886.34K
TypeSH
Market value$44.75M
3.55%
Sole
886.34K
Shared
0.00
None
0.00
Rapport Therapeutics Inc
SOLEShares2M
TypeSH
Market value$40.87M
3.24%
Sole
2M
Shared
0.00
None
0.00
Arrivent BioPharma Inc
SOLEShares1.70M
TypeSH
Market value$39.87M
3.16%
Sole
1.70M
Shared
0.00
None
0.00
Y-mAbs Therapeutics Inc
SOLEShares2.19M
TypeSH
Market value$28.85M
2.29%
Sole
2.19M
Shared
0.00
None
0.00
Dyne Therapeutics Inc
SOLEShares772.07K
TypeSH
Market value$27.73M
2.20%
Sole
772.07K
Shared
0.00
None
0.00
Cogent Biosciences Inc
SOLEShares2.27M
TypeSH
Market value$24.46M
1.94%
Sole
2.27M
Shared
0.00
None
0.00
Savara Inc
SOLEShares5.66M
TypeSH
Market value$24.01M
1.91%
Sole
5.66M
Shared
0.00
None
0.00
Novartis AG
SOLEShares200K
TypeSH
Market value$23.00M
1.83%
Sole
200K
Shared
0.00
None
0.00
Inozyme Pharma Inc
SOLEShares4.28M
TypeSH
Market value$22.39M
1.78%
Sole
4.28M
Shared
0.00
None
0.00
Jazz Pharmaceuticals PLC
SOLEShares188.56K
TypeSH
Market value$21.01M
1.67%
Sole
188.56K
Shared
0.00
None
0.00
Insmed Inc
SOLEShares286.31K
TypeSH
Market value$20.90M
1.66%
Sole
286.31K
Shared
0.00
None
0.00
Syndax Pharmaceuticals Inc
SOLEShares787K
TypeSH
Market value$15.15M
1.20%
Sole
787K
Shared
0.00
None
0.00
Rhythm Pharmaceuticals
SOLEShares276.68K
TypeSH
Market value$14.50M
1.15%
Sole
276.68K
Shared
0.00
None
0.00
Edwards Lifesciences Corp
SOLEShares202.90K
TypeSH
Market value$13.39M
1.06%
Sole
202.90K
Shared
0.00
None
0.00
Boston Scientific Corp
SOLEShares135.82K
TypeSH
Market value$11.38M
0.90%
Sole
135.82K
Shared
0.00
None
0.00
Pharvaris N V
SOLEShares600.30K
TypeSH
Market value$11.12M
0.88%
Sole
600.30K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Natera IncSOLE | COM | 1.55M | SH | $196.81M 15.62% | 1.55M | 0.00 | 0.00 |
Vera Therapeutics IncSOLE | CL A | 2.79M | SH | $123.49M 9.80% | 2.79M | 0.00 | 0.00 |
Novo-Nordisk A SSOLE | ADR | 726.33K | SH | $86.48M 6.86% | 726.33K | 0.00 | 0.00 |
AstraZeneca PLCSOLE | SPONSORED ADR | 809.41K | SH | $63.06M 5.00% | 809.41K | 0.00 | 0.00 |
IDEAYA Biosciences IncSOLE | COM | 1.75M | SH | $55.42M 4.40% | 1.75M | 0.00 | 0.00 |
Elanco Animal Health IncSOLE | COM | 3.52M | SH | $51.69M 4.10% | 3.52M | 0.00 | 0.00 |
BioAge Labs IncSOLE | COM | 2.30M | SH | $47.94M 3.80% | 2.30M | 0.00 | 0.00 |
Axsome Therapeutics IncSOLE | COM | 529.53K | SH | $47.59M 3.78% | 529.53K | 0.00 | 0.00 |
Incyte CorpSOLE | COM | 714.18K | SH | $47.21M 3.75% | 714.18K | 0.00 | 0.00 |
Soleno Therapeutics IncSOLE | COM | 886.34K | SH | $44.75M 3.55% | 886.34K | 0.00 | 0.00 |
Rapport Therapeutics IncSOLE | COM | 2M | SH | $40.87M 3.24% | 2M | 0.00 | 0.00 |
Arrivent BioPharma IncSOLE | COM | 1.70M | SH | $39.87M 3.16% | 1.70M | 0.00 | 0.00 |
Y-mAbs Therapeutics IncSOLE | COM | 2.19M | SH | $28.85M 2.29% | 2.19M | 0.00 | 0.00 |
Dyne Therapeutics IncSOLE | COM | 772.07K | SH | $27.73M 2.20% | 772.07K | 0.00 | 0.00 |
Cogent Biosciences IncSOLE | COM | 2.27M | SH | $24.46M 1.94% | 2.27M | 0.00 | 0.00 |
Savara IncSOLE | COM | 5.66M | SH | $24.01M 1.91% | 5.66M | 0.00 | 0.00 |
Novartis AGSOLE | SPONSORED ADR | 200K | SH | $23.00M 1.83% | 200K | 0.00 | 0.00 |
Inozyme Pharma IncSOLE | COM | 4.28M | SH | $22.39M 1.78% | 4.28M | 0.00 | 0.00 |
Jazz Pharmaceuticals PLCSOLE | SHS USD | 188.56K | SH | $21.01M 1.67% | 188.56K | 0.00 | 0.00 |
Insmed IncSOLE | COM PAR $.01 | 286.31K | SH | $20.90M 1.66% | 286.31K | 0.00 | 0.00 |
Syndax Pharmaceuticals IncSOLE | COM | 787K | SH | $15.15M 1.20% | 787K | 0.00 | 0.00 |
Rhythm PharmaceuticalsSOLE | COM | 276.68K | SH | $14.50M 1.15% | 276.68K | 0.00 | 0.00 |
Edwards Lifesciences CorpSOLE | COM | 202.90K | SH | $13.39M 1.06% | 202.90K | 0.00 | 0.00 |
Boston Scientific CorpSOLE | COM | 135.82K | SH | $11.38M 0.90% | 135.82K | 0.00 | 0.00 |
Pharvaris N VSOLE | COM | 600.30K | SH | $11.12M 0.88% | 600.30K | 0.00 | 0.00 |
Page 1 of 3